BioSpace News Archive

American Association of Orthopaedic Surgeons President Joseph A. Bosco III, MD, FAAOS, issued the following statement in response to the newly released Calendar Year 2021 Hospital Outpatient Prospective Payment System proposed rule.

Amarin Corporation plc, announced support for an investigator-initiated trial to study the effects of icosapent ethyl on laboratory-confirmed viral upper respiratory infection rates, clinical impact and outcomes, especially with severe acute respiratory syndrome coronavirus 2 infection which causes COVID-19, in adults with established atherosclerotic cardiovascular disease who are at elevated risk of experiencing moderate to severe COVID-19.1,2

Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”) will release its financial results for the second quarter ended June 30, 2020, before the market opens on Thursday, August 13, 2020.

AAKP’s 3rd Annual Policy Summit highlights progress and barriers related to the 2019 Executive Order on Advancing American Kidney Health and key Congressional issues

Cerus Corporation (Nasdaq:CERS) announced today that INTERCEPT Blood Systems disposable kit shipments have surpassed 7.5 million treatable platelet and plasma doses globally since commercial launch. “This is a significant milestone for Cerus and highlights the scope our technology has had within the transfusion industry and on the millions of patients worldwide transfused with INTERCEPT treated platelet and plasma co

Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced sales of more than $550,000 for the month of July. Sales were driven by 3D Med ANDis auto-extraction ma

Emerging Technology video presentation describing swine studies using AC5-GTM for submucosal lifting and management of gastrointestinal bleeding in endoscopic resection

The SebastianStrong Foundation has selected Yale Cancer Center’s Ranjithmenon Muraleedharan, M.D., as the recipient of the organization’s 2020 Discovery Science Award.